Gregory Lucier - Invuity Insider

Invuity Inc -- USA Stock  

USD 3.70  0.20  5.13%

Chairman of the Board

Mr. Gregory T. Lucier was appointed as Chairman of the Board of the Company., effective December 31, 2015. Mr. Lucier has served as a member of our board of directors since October 2014 and as the Chairman of our board of directors since December 2015. Since May 2015, Mr. Lucier has served as the Chief Executive Officer of NuVasive, a publicly traded medical device company. From November 2008 to February 2014, Mr. Lucier was Chairman of the board of directors and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. In May 2003, Mr. Lucier joined Life Technologies predecessor company, Invitrogen Corporationrationration, as Chief Executive Officer. Prior to Life Technologies, Mr. Lucier was a corporate officer at General Electric Company from 1994 to 2003 where he served in a variety of leadership roles. Mr. Lucier serves on the board of directors of NuVasive and Catalent, Inc
Age: 52  Chairman Since 2015  MBA    
Lucier received a B.S. with honors in industrial engineering from Pennsylvania State University and an M.B.A. from Harvard Business School. We believe Mr. Lucier is qualified to serve as a member of our board of directors because of his management and operational experience in the healthcare industry.

Gregory Lucier Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (41.65) % which means that it has lost $41.65 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (237.71) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.98 M in liabilities with Debt to Equity (D/E) ratio of 641.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invuity Inc has Current Ratio of 2.5 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 3 records


Michael MussallemEdwards Lifesciences Corporatio
Jeffrey EberweinDigirad Corporation
Erez RaphaelDarioHealth Corp

Entity Summary

Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity is traded on NASDAQ General Markets in USA.Invuity Inc (IVTY) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 172 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Equity Valuation Now

Equity Valuation

Check real value of public entities based on technical and fundamental data
Hide  View All  NextLaunch Equity Valuation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Invuity Inc to your portfolio

Top Management

Invuity Inc Leadership Team
Robert Gerberich, President
Douglas Heigel, VP
Daniel Wolterman, Director
Alex Vayser, Founder
William Burke, Director, MBA
Philip Sawyer, CEO, MBA
Eric Roberts, Director
Andrew Sale, President
Scott Flora, Director
Gregory Brown, Executive, MBA
James Mackaness, CFO
Steve Annen, President
Joseph Guido, President, MBA
Randall Lipps, Director
Paul Davison, VP
Reza Zadno, Director, Ph.D
Brett Robertson, Executive
Gregory Lucier, Chairman, MBA
Marcia Fish, Executive, MBA

Stock Performance

Invuity Performance Indicators